A detailed history of Integrated Advisors Network LLC transactions in Kymera Therapeutics, Inc. stock. As of the latest transaction made, Integrated Advisors Network LLC holds 6,218 shares of KYMR stock, worth $253,818. This represents 0.01% of its overall portfolio holdings.

Number of Shares
6,218
Holding current value
$253,818
% of portfolio
0.01%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 24, 2024

BUY
$30.16 - $52.4 $187,534 - $325,823
6,218 New
6,218 $294,000
Q1 2024

May 03, 2024

BUY
$22.9 - $43.57 $142,392 - $270,918
6,218 New
6,218 $249,000
Q2 2022

Aug 12, 2022

SELL
$14.13 - $42.55 $87,860 - $264,575
-6,218 Closed
0 $0
Q3 2021

Nov 15, 2021

SELL
$47.8 - $66.66 $358,500 - $499,950
-7,500 Reduced 54.67%
6,218 $365,000
Q2 2021

Aug 06, 2021

BUY
$31.08 - $51.95 $426,355 - $712,650
13,718 New
13,718 $665,000

Others Institutions Holding KYMR

About Kymera Therapeutics, Inc.


  • Ticker KYMR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 54,705,800
  • Market Cap $2.23B
  • Description
  • Kymera Therapeutics, Inc., a biopharmaceutical company, focuses on discovering and developing novel small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body's own natural protein degradation system. It engages in developing IRAK4 program, which is in Phase I clinical trial for the treatment of immunolo...
More about KYMR
Track This Portfolio

Track Integrated Advisors Network LLC Portfolio

Follow Integrated Advisors Network LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Integrated Advisors Network LLC, based on Form 13F filings with the SEC.

News

Stay updated on Integrated Advisors Network LLC with notifications on news.